EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro and In Vivo Studies of Melanoma Cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM

Stefano Vito Boccadamo Pompili iD, Sophia Fanzini, Melitta Schachner, Suzie Chen

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Stefano Vito Boccadamo Pompili und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology "V. Erspamer", Sapienza University, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Cell Movement, Melanoma, Neural Cell Adhesion Molecule L1. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, Busch Biomedical Grant, Rutgers University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma, the deadliest type of skin cancer, has a high propensity to metastasize to other organs, including the brain, lymph nodes, lungs, and bones. While progress has been made in managing melanoma with targeted and immune therapies, many patients do not benefit from these current treatment modalities. Tumor cell migration is the initial step for invasion and metastasis. A better understanding of the molecular mechanisms underlying metastasis is crucial for developing therapeutic strategies for metastatic diseases, including melanoma. The cell adhesion molecule L1CAM (CD171, in short L1) is upregulated in many human cancers, enhancing tumor cell migration. Earlier studies showed that the small-molecule antagonistic mimetics of L1 suppress glioblastoma cell migration in vitro. This study aims to evaluate if L1 mimetic antagonists can inhibit melanoma cell migration in vitro and in vivo. We showed that two antagonistic mimetics of L1, anagrelide and 2-hydroxy-5-fluoropyrimidine (2H5F), reduced melanoma cell migration in vitro. In in vivo allograft studies, only 2H5F-treated female mice showed a decrease in tumor volume.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell MovementMelanomaNeural Cell Adhesion Molecule L1AnimalsFemaleHumansMiceCell Line, TumorPyrimidinesSkin NeoplasmsXenograft Model Antitumor AssaysQuinazolines

Stichwörter der Autor:innen

2-hydroxy-5-fluoropirimidineCD171L1CAManagrelidecell migration in vitroin vivo allograftmelanoma

Substanzen

Neural Cell Adhesion Molecule L1PyrimidinesanagrelideQuinazolines

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology "V. Erspamer", Sapienza University, 00185 Rome, Italy.
  • Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
  • Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA.
  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.
  • VA New Jersey Health System, East Orange, NJ 07018, USA.

ORCID-Profile: Stefano Vito Boccadamo Pompili

Förderung

  • BLRD VA
  • Busch Biomedical Grant, Rutgers University

Zitieren

APA

Pompili, S. V. B., Fanzini, S., Schachner, M., & Chen, S. (2024). In Vitro and In Vivo Studies of Melanoma Cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094811

Vancouver

Pompili SVB, Fanzini S, Schachner M, Chen S. In Vitro and In Vivo Studies of Melanoma Cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094811

BibTeX
@article{Pompili2024,
  author = {Pompili, Stefano Vito Boccadamo and Fanzini, Sophia and Schachner, Melitta and Chen, Suzie},
  title = {In Vitro and In Vivo Studies of Melanoma Cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094811}
}
Kostenlos starten →